Li Q et al. proved for the first time that genetic variations in the transforming growth factor-β (TGF-β), PI3K/protein kinase B (AKT) pathways were associated with an increased risk of brain metastasis in NSCLC patients (67, 68). The gene discussed is TGFB1; the disease is non-small cell lung carcinoma.